Cartesian Therapeutics Inc. (RNAC) Debt to Equity Ratio
Cartesian Therapeutics Inc. (RNAC) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2016-12-31 | 0.62 |
| 2017-12-31 | 0.95 |
| 2018-12-31 | -9.21 |
| 2019-12-31 | 10.86 |
| 2020-12-31 | -10.19 |
| 2021-12-31 | 6.10 |
| 2022-12-31 | 0.77 |
| 2023-12-31 | -1.01 |
| 2024-12-31 | -64.96 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("RNAC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RNAC | $6.14 | -2.23% | 0.12M |
| 3 | ||||
| 4 | ||||
| 5 |